Back
CureVac NV Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
CVAC
CureVac NV
Last Price:
2.56
Seasonality Move:
-12.26%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...CureVac NV Price Quote
$2.56
+0.07 (+2.81%)
(Updated: November 21, 2024 at 5:55 PM ET)
CureVac NV Key Stats
Sell
30
CureVac NV (CVAC)
is a Sell
Day range:
$2.37 - $2.55
52-week range:
$2.22 - $6.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.97
P/B ratio:
0.72%
Volume:
855.5K
Avg. volume:
486.4K
1-year change:
-55.3%
Market cap:
$578.8M
Revenue:
$58.2M
EPS:
$0.55
How Much Does CureVac NV Make?
-
How Much Are CureVac NV's Sales Annually?
CVAC Revenues are $58.2M -
How Much Profit Does CureVac NV's Make A Year?
CVAC net income is -$281.7M
Is CureVac NV Growing As A Company?
-
What Is CureVac NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 29.27% -
What Is CureVac NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CureVac NV Stock Price Performance
-
Did CureVac NV Stock Go Up Last Month?
CureVac NV share price went down by -11.07% last month -
Did CVAC's Share Price Rise Over The Last Year?
CVAC share price fell by -55.3% over the past 1 year
What Is CureVac NV 52-Week High & Low?
-
What Is CureVac NV’s 52-Week High Share Price?
CureVac NV has traded as high as $6.30 over the past 52 weeks -
What Is CureVac NV’s 52-Week Low Share Price?
CureVac NV has traded as low as $2.22 over the past 52 weeks
CureVac NV Price To Free Cash Flow
-
Is CureVac NV Stock Overvalued?
CureVac NV is trading at a price to free cash flow ratio of 5.43 -
Is CureVac NV Stock Undervalued?
CureVac NV EV to Free Cash Flow ratio is -0.38 -
What Is CureVac NV’s Price Earnings Growth Ratio?
CVAC PEG ratio is 0.00 -
Is CureVac NV Trading At A Premium To Earnings?
CureVac NV EV to EBIT ratio is -0.25
Is It Risky To Buy CureVac NV?
-
How Much Debt Does CureVac NV Have?
Total long term debt quarterly is $0 -
How Much Cash Does CureVac NV Have?
Cash and short term investments quarterly total is $619.8M -
What Is CureVac NV’s Book Value Per Share?
Book value per share is 3.61
Is CureVac NV Cash Flow Positive?
-
What Is CVAC Cash Flow From Operations?
Cash flow from operations (TTM) is $139.4M -
What Is CureVac NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$7.2M -
What Is CureVac NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$32.8M
CureVac NV Return On Invested Capital
-
Is Management Doing A Good Job?
CVAC return on invested capital is 21.3% -
What Is CureVac NV Return On Assets?
ROA measures how assets are converting to revenues and is 15.24% -
What Is CVAC Return On Equity?
ROE is a measure of profitability and is 21.3%
CureVac NV Earnings Date & Stock Price
-
What Is CureVac NV's Stock Price Today?
A single share of CVAC can be purchased today for 2.49 -
What Is CureVac NV’s Stock Symbol?
CureVac NV trades on the nasdaq under the ticker symbol: CVAC -
When Is CureVac NV’s Next Earnings Date?
The next quarterly earnings date for CureVac NV is scheduled on April 24, 2025 -
When Is CVAC's next ex-dividend date?
CureVac NV's next ex-dividend date is November 22, 2024 -
How To Buy CureVac NV Stock?
You can buy CureVac NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CureVac NV Competitors
-
Who Are CureVac NV's Competitors?
Below is a list of companies who compete with CureVac NV or are related in some way:
CureVac NV Dividend Yield
-
What Is CVAC Dividend Yield?
CureVac NV’s dividend yield currently is 0% -
What Is CureVac NV’s Payout Ratio?
CureVac NV’s payout ratio is 0% -
When Did CureVac NV Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is CureVac NV’s Dividend Per Share?
CureVac NV pays a dividend of $0.00 per share
CureVac NV Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 3.84% |
| Revenue: | 2926.77% | 249.7% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 7.46 |
| Upside from Last Price: | 199.75% |